1. An Integrative Serum Pharmacology-Based Approach to Study the Anti-Tumor Activity of B. paniculatum Aqueous Bulb Extract on the Human Hepatocellular Carcinoma Cell Line BEL-7404
    Xuesong Feng et al, 2020, Front. Pharmacol. CrossRef
  2. Hepigenetics: A Review of Epigenetic Modulators and Potential Therapies in Hepatocellular Carcinoma
    Mohamed H. Yousef et al, 2020, BioMed Research International CrossRef
  3. Role of long non-coding RNA H19 in therapy resistance of digestive system cancers
    Jingting Wang et al, 2021, Mol Med CrossRef
  4. Role of lncRNA NR2F1-AS1 and lncRNA H19 Genes in Hepatocellular Carcinoma and Their Effects on Biological Function of Huh-7
    Wen-Chao Ji et al, 2021, CMAR CrossRef
  5. The role of H19 lncRNA in conferring chemoresistance in cancer cells
    Soudeh Ghafouri-Fard et al, 2021, Biomedicine & Pharmacotherapy CrossRef
  6. How metformin affects various malignancies by means of microRNAs: a brief review
    Nahid Alimoradi et al, 2021, Cancer Cell Int CrossRef
  7. Combined Inhibition of TGF-β1-Induced EMT and PD-L1 Silencing Re-Sensitizes Hepatocellular Carcinoma to Sorafenib Treatment
    Ritu Shrestha et al, 2021, JCM CrossRef
  8. The lncRNAs in HBV-Related HCCs: Targeting Chromatin Dynamics and Beyond
    Vincenzo Alfano et al, 2021, Cancers CrossRef
  9. Targeting Long Non-Coding RNAs in Hepatocellular Carcinoma: Progress and Prospects
    Xinrong Lin et al, 2021, Front. Oncol. CrossRef
  10. Effect of the Hypoxia Inducible Factor on Sorafenib Resistance of Hepatocellular Carcinoma
    Zhi Zeng et al, 2021, Front. Oncol. CrossRef
  11. LncRNA H19 modulated by miR-146b-3p/miR-1539-mediated allelic regulation in transarterial chemoembolization of hepatocellular carcinoma
    Yemei Song et al, 2021, Arch Toxicol CrossRef
  12. The Role of Non-Coding RNAs in the Sorafenib Resistance of Hepatocellular Carcinoma
    Xinyao Hu et al, 2021, Front. Oncol. CrossRef
  13. Keep your eyes peeled for long noncoding RNAs: Explaining their boundless role in cancer metastasis, drug resistance, and clinical application.
    Ganesh Kumar Barik et al, 2021, Biochim Biophys Acta Rev Cancer CrossRef
  14. Long Noncoding RNA H19: A Key Player in Liver Diseases.
    Yanyan Wang et al, 2021, Hepatology CrossRef
  15. The Role of Long Non-Coding RNA and microRNA Networks in Hepatocellular Carcinoma and Its Tumor Microenvironment
    Tingting Shi et al, 2021, IJMS CrossRef
  16. Functional and Clinical Significance of Dysregulated microRNAs in Liver Cancer
    Po-Shuan Huang et al, 2021, Cancers CrossRef
  17. Emerging role of long noncoding RNAs in recurrent hepatocellular carcinoma
    Yuan Fang et al, 2021, WJCC CrossRef
  18. null
    Julie Sanceau et al, 2022 CrossRef
  19. null
    Rahul Kumar Vempati et al, 2022 CrossRef
  20. The long non-coding RNA LIMT inhibits metastasis of hepatocellular carcinoma and is suppressed by EGF signaling
    Yu Hu et al, 2022, Mol Biol Rep CrossRef
  21. Long non-coding RNAs (lncRNAs); roles in tumorigenesis and potentials as biomarkers in cancer diagnosis
    Sajad Najafi et al, 2022, Experimental Cell Research CrossRef
  22. Noncoding RNA-mediated molecular bases of chemotherapy resistance in hepatocellular carcinoma
    Qikuan He et al, 2022, Cancer Cell Int CrossRef
  23. Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy
    Mehrdad Hashemi et al, 2022, Pharmacological Research CrossRef
  24. The role of lncRNA H19 in tumorigenesis and drug resistance of human Cancers
    Xun Zhang et al, 2022, Front. Genet. CrossRef
  25. Cysteine-rich 61(CYR61) alleviates cyclophosphamide-induced proliferation inhibition in ovarian granulosa cells via suppressing NLRP3/caspase1-mediated pyroptosis
    Hongxia Xu et al, 2023, Hum Exp Toxicol CrossRef
  26. null
    Xinxin Chen et al, 2023 CrossRef
  27. Long Noncoding RNA H19: A Novel Oncogene in Liver Cancer
    Yanyan Wang et al, 2023, ncRNA CrossRef
  28. null
    Sandhik Nandi et al, 2023 CrossRef
  29. Long noncoding RNA (lncRNA) H19: An essential developmental regulator with expanding roles in cancer, stem cell differentiation, and metabolic diseases
    Junyi Liao et al, 2023, Genes & Diseases CrossRef
  30. The effects of intracellular and exosomal ncRNAs on cancer progression
    Yang-Hsiang Lin, 2023, Cancer Gene Ther CrossRef
  31. LncRNA H19: a novel player in the regulation of diabetic kidney disease
    Qinrui Wu et al, 2023, Front. Endocrinol. CrossRef
  32. Long non-coding RNA H19 mediates the miR-29b/transforming growth factor-β1/Drosophila mothers against decapentaplegic 3 signalling pathway to promote bladder fibrosis in diabetic rats
    Ji Sun et al, 2024, Int Urol Nephrol CrossRef